ClinicoEconomics and Outcomes Research
Volume 14, 2022 - Issue
Original Research
Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost–Benefit Analysis
, 
, &
Matthew E BorregoCollege of Pharmacy, University of New Mexico, Albuquerque, NM, USAhttps://orcid.org/0000-0002-7068-8029View further author information
https://orcid.org/0000-0002-7068-8029View further author information, Gretchen M RayCollege of Pharmacy, University of New Mexico, Albuquerque, NM, USAhttps://orcid.org/0000-0002-4236-1539View further author information
https://orcid.org/0000-0002-4236-1539View further author information & Melissa H RobertsCollege of Pharmacy, University of New Mexico, Albuquerque, NM, USACorrespondence[email protected]
https://orcid.org/0000-0002-1314-4906View further author information
https://orcid.org/0000-0002-1314-4906View further author information